TY - JOUR
T1 - Clinical advances in the treatment of pulmonary arterial hypertension
AU - Chakinala, Murali M.
N1 - Publisher Copyright:
© 2019 National Association of Managed Care Physicians, Inc.. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Pulmonary arterial hypertension (PAH) is a costly disease, both financially and personally. Survival rates have improved with targeted therapies, but could probably be improved more with aggressive management of medications to achieve low-risk status. Management of these patients requires complex, expensive regimens, which are likely best managed by a multidisciplinary team in a pulmonary hypertension center.
AB - Pulmonary arterial hypertension (PAH) is a costly disease, both financially and personally. Survival rates have improved with targeted therapies, but could probably be improved more with aggressive management of medications to achieve low-risk status. Management of these patients requires complex, expensive regimens, which are likely best managed by a multidisciplinary team in a pulmonary hypertension center.
UR - http://www.scopus.com/inward/record.url?scp=85118927889&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85118927889
SN - 1094-1525
VL - 22
SP - 73
EP - 78
JO - Journal of Managed Care Medicine
JF - Journal of Managed Care Medicine
IS - 3
ER -